Ipsen Pharma GmbH


Industry / private company

Location:
Ettlingen, Germany


Publications in cooperation with FAU scientists


Pavel, M.E., Denecke, T., Lahner, H., Hoersch, D., Rinke, A., Koch, A.,... Raderer, M. (2018). Disease Control in Progressive Pancreatic and Intestinal Neuroendocrine Tumors by Combined Treatment with Lanreotide Autogel and Temozolomide: The SONNET Study. (pp. 202-202).
Lapuerta, P., Kulke, M.H., Pavel, M.E., Biran, T., Fleming, R., Zacks, J.S.,... Warner, R.R.P. (2018). Integrated Safety Analysis of Telotristat Ethyl in Patients With Carcinoid Heart Disease. (pp. 345-345).
Hoersch, D., Raderer, M., Lahner, H., Rinke, A., Denecke, T., Koch, A.,... Pavel, M.E. (2017). Combined lanreotide autogel and temozolomide in progressive neuroendocrine tumours: an interim safety analysis of the SONNET study. (pp. 238-238).

Last updated on 2018-26-11 at 14:08